In
a study by Schenck and Mahowald,
146
of 170 (86%) subjects achieved complete or nearly complete control of
sleep disorders.
24
(14.1%) subjects achieved a lesser degree of control.
27
(15.9%) subjects had one or more adverse effects such as mild morning
sedation, subjective memory dysfunction, alopecia, and various other symptoms.
For
patients suffering from RBD specifically, treatment with Clonazepam eliminates
the disorder 90% of the time (www.sleepfoundation.org).
If
Clonazepam doesn’t work, antidepressants or melatonin may be used to reduce
violent behavior (www.sleepfoundation.org).
Parasomnias
are treated with Clonazepam (a benzodiazepine) which acts as a
potent anticonvulsant.